Parvovax, süsteemulsioon sigadele
Parvovax, süsteemulsioon sigadele
Not authorised
- Porcine parvovirus, Inactivated
Product identification
Medicine name:
Parvovax, süsteemulsioon sigadele
Active substance:
- Porcine parvovirus, Inactivated
Target species:
This information is not available for this product.
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Porcine parvovirus, Inactivated2.00/haemagglutination inhibiting unit(s)1.00dose
Pharmaceutical form:
-
Emulsion for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AA02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Estonia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
- Ceva-Phylaxia Zrt.
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1201
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Estonian (PDF)
Published on: 3/02/2022
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Estonian (PDF)
Published on: 17/04/2023